Company SciSparc Ltd.

Equities

SPRC

IL0010951403

Pharmaceuticals

Market Closed - Nasdaq 03:56:46 2024-06-04 pm EDT 5-day change 1st Jan Change
0.9441 USD +2.43% Intraday chart for SciSparc Ltd. -14.17% -80.65%

Business Summary

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Number of employees: 3

Sales per Business

USD in Million2022Weight2023Weight Delta
Drug Development
100.0 %
- - 3 100.0 % -

Sales per region

USD in Million2022Weight2023Weight Delta
Israel
100.0 %
1 100.0 % 3 100.0 % +113.73%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 708,438 708,267 ( 99.98 %) 0 99.98 %

Shareholders

NameEquities%Valuation
Yorkville Advisors Global LP
2.256 %
55,293 2.256 % 69 669 $
UBS Securities LLC
0.3655 %
8,958 0.3655 % 11 287 $
RhumbLine Advisers LP
0.1413 %
3,464 0.1413 % 4 365 $
340 0.0139 % 428 $
Amitay Weiss
0.001020 %
25 0.001020 % 32 $
Lior Vider
0.000000 %
0 0.000000 % - $
Amnon Ben Shay
0.000000 %
0 0.000000 % - $
0 0.000000 % - $
Alon Dayan
0.000000 %
0 0.000000 % - $
Oz Adler
0.000000 %
0 0.000000 % - $

Holdings

NameEquities%Valuation
7,692 0.24% 9,230 $

Company contact information

SciSparc Ltd.

20 Raul Wallenberg Street` Tower A

6971916, Tel Aviv

+

http://www.scisparc.com
address SciSparc Ltd.(SPRC)